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ABSTRACT 
 
Febrile neutropenia may have a high morbidity and mortality impact for the patient. The death rate of febrile 
neutropenia in 2002 was 38.8%, while in 2009 was 27.3%. The difference in mortality rates could caused by several 
factors such as availability of the Neutropenic Fever Management Guidelines in 2006, in addition to infrastructure, 
human resources and equipment. This study aims to determine the effect of the availability of the guideline and other 
factors to cancer mortality rate in the compromised immune isolation room of Dharmais Hospital. This study is a 
cross-sectional retrospective study which investigate mortality rates and compare with adherence to febrile 
neutropenia guidelines for the period 2008-2012. Data were taken from the patient's medical record file, then analyzed 
using univariate and bivariate analysis. The mortality rate in the period 2008-2012 was 20,7%. The effect of age, sex, 
and degree of risk factor on mortality was not significantly different (p=0,409, p=0,404, and p=0,324). The proportion 
of deaths was higher in patients borne by third parties (26.8%) than in the case of personal (10%) although not 
statistically significant (p=0,065). Of the three types of adherence, only one had a significant effect of adherence to 
treatment flow (p=0,033).  
 
Keywords: guidelines of febrile neutropenia; compromised immune isolation room; mortality rate. 
 
 
 
INTRODUCTION 
 
Febrile neutropenia (FN) is defined as an oral temperature 
>38.5oC or two consecutive readings of >38.0oC for 2 
hours and an absolute neutrophil count <0.5x109/l, or 
expected to fall below 0.5x109/l).1 Febrile neutropenia is a 
common complication in cancer patients who are 
undergoing treatment and may have impacts on 
morbidity and mortality.1-3 Rates of neutropenia who 
receive chemotherapy for solid tumors was 5-10%, 
whereas patients with hematological malignancy have 
rates more than 20%, and incidence in patients who have 
bone marrow transplant was 70-100%.4 Dharmais 
Hospital National Cancer Center, Jakarta recorded febrile 
neutropenia death rate in 1999, 2000, and 2002 in a row 
was 12,5%, 22,5%, and 38,8%. While in Indonesia, there 
is no national data about the magnitude of neutropenic 
febrile death rate. 
Mortality rate due to neutropenic fever is increasing, 
except in 2009, there was a considerable decrease in 
mortality rate. From 38,8% in 2002 became 27,3% in 
2009. The difference in mortality rate may be due to 
several factors, including the availability of guideline on 
neutropenic fever in 2006, in addition to infrastructure, 
human resources, equipment, and systems. 
 
The current management of neutropenia includes 
modification of chemotherapy doses, prolonged dose 
interval, and primary prophylaxis with recombinant G-
CFS.7 Guidelines of FN in cancer patients itself aims to 
achieve the same perception and understanding of 
neutropenic fever management in Indonesia; more 
effective, safe, efficient and rational use of antibiotics; 
avoid accelerated antibiotic resistance; and obtain 
empirical data that can be continuously updated.6 
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The more detail clarification and evaluation about 
guidelines of febrile neutropenia management in isolation 
room, Dharmais Hospital National Cancer Center which 
was enforced since 2006 is required. This evaluation 
should have an outcome in mortality rate and factors that 
influence. A clinical audit of this management guidelines 
has not been done. The aim of this study is to obtain the 
effects availability of guideline management and other 
factors in mortality rate of on neutropenic fever patients in 
Dharmais Hospital National Cancer Center in the year 
2008-2012.  
 
RESEARCH METHODOLOGY 
 
This is a retrospective, cross-sectional study using 
secondary data from Dharmais Hospital National Cancer 
Center in the period between 2008-2012. The data were 
obtained from the medical records. Subjects are all of 
patients who were diagnosed febrile neutropenia in 
Dharmais Hospital National Cancer Center. 
 
Inclusion criteria for subjects are treated in isolation room, 
fever (axillary temperature ≥380C at two measurements 
within an hour or more for solid tumor, ≥37,50C for 
hematologic cancer, or ≥38,30C at first measurement and 
no signs of non-infection), neutropenia (neutrophils <500 
cells/mm3 or <1000 cells/mm3 with downward trend 
towards 500 cells/mm3 in next two days). While 
exclusion criteria of this study are incomplete data, both 
related to recording in medical record or loss of data in the 
medical record. Data of patients who met inclusion and 
exclusion criteria were collected and then tabulated. While 
the data of patients' compliance was done scoring to 
perform statistical analysis. 
 
The variables seen in this study were medication flow 
adherence, medication principal adherence, initiation or 
termination of medication, age, gender, degree of 
neutropenic fever, and cost capability. All of these factors 
were associated with mortality rate. 
 
Ethical Approval 
 
This study used patients’ medical record data 
retrospectively and did not intervene the patient. This 
study was unrelated to patient safety and did not require 
informed consent. Ethics in this study includes respecting 
subject's privacy by not displaying identity, either name or 
origin address of subjects and using initials as substitution 
of identity. 
 
RESULTS AND DISCUSSION 
 
Data which obtained through patient registration in 
isolation room of immunity decreased throughout 2008-
2012 were 212. Data which did not meet fever criteria was 
43 cases, neutropenia criteria were 2 cases, and 
incomplete data were 56 cases. So total data that could be 
processed was 111 cases. 
 
Characteristics of Subject’s Demography 
 
The mean of age was 37,8 years old with deviation 
standard 13,8. The youngest was 13 and the oldest was 70. 
Then subjects were divided into two groups. Younger 
patients (13-38) was 58 patients (52,3%) and the rest 
(47,7%) were over 38 years old. In this study, men 
(57,7%) are more likely to have neutropenic fever than 
women (42,3%). Neutropenic fever patients which have 
the third party as person in charge were 64%. The 
guarantors as the third party include Jaminan Perusahaan, 
Asuransi, Askes, Jamkesda, and Jamkesmas. Based on 
the degree of risk factor, high risk became the most 
commonly obtained. The degree of risk factor was based 
on Guideline of FN Management (show in table 1). 
 
Characteristics of Physician Compliance on Guideline 
of Neutropenic Fever Management 
 
Physician compliance of management algorithm was 
based on Guideline of FN Management that includes 5 
parameters: (1) empirical antibiotics utilization at the start 
of treatment according to degree of risk, (2) replace the 
type of antibiotic in case of worsening after 72 hours, (3) 
Did examination for reevaluation after 72 hours, (4) 
provide anti-fungal drugs according to degree of risk, (5) 
discontinue antibiotic/anti-fungal treatment according to 
degree of risk. 
 
While parameter of physician compliance on treatment 
principal, there are (1) start antibiotic as soon as possible, 
(2) empirical according to guideline, (3) utilization of 
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bactericidal antibiotic, not bacteriostatic, and (4) utilization 
of broad-spectrum antibiotic.  Both groups of parameter 
were scored, 0 (zero) is not appropriate and 5 (five) if 
appropriate. Categorized obedient if the total score is ≥15. 
 
Doctors who adhere to the management algorithm 
(67,6%) are more than those who do not (32,4%). As well 
as management algorithm, doctors who adhere to 
treatment principal (81,1%) were are more than those 
who do not (18,9%) (Table 2). 
For the starting treatment criteria, the parameter used 
started at <24 hours are obedient and started at >24 hours 
are disobedient. Doctors who adhere to starting treatment 
(81,1%) were are more than those who do not (18,9%) 
(show in table 2). 
 
Number of Cases 
 
Life cases (79,3%) were more than death cases (20,7%). 
This data showed that the number of death cases in 
Dharmais Cancer Hospital at the period 2008-2012 was 
20,7%. 
 
Data Analysis 
 
This study found that adherence to management 
algorithm had a significant effect on death rate compared 
with disobedient. Death rate in obedient was 15,5% and 
disobedient was 37% (p=0,033). While the adherence to 
treatment principle and starting treatment had no 
significant effect on death rate of neutropenic fever 
(respectively, p=0,556 and p=0,556) (show in table 3). 
 
Other factors that were seen in this study were age, 
gender, a person in charge, and degree of risk. All of this 
factors had no significant effect in neutropenic fever 
death rate (p>0,05) (show in table 4).  
 
Data that could be processed from isolation room during 
the period 2008-2012 was 111 data (52,35%). Data that 
could not be processed was caused by did not meet the 
criteria for neutropenic fever (21,2%) and data was 
incomplete (26,45%). This problem occurred due to 
medical record document that in the 10 years period is not 
used anymore, considered to be inactive and will be 
transferred to the warehouse. In addition, a neutropenic 
fever diagnosis was rarely written as a diagnosis, both 
primary or secondary diagnose in the medical record. 
Clinical guidelines are essential if problems are frequent or 
costly, there is wide variation in management practices 
and there is sufficient scientific evidence for optimal 
implementation. Guideline of neutropenic fever management 
qualified as a good clinical guide and can be implemented 
because it meets most of prescribed requirements, ie 
certified areas which clinically important, based on 
Randomized Controlled Trials, the intended target is very 
clear, easy to understand, supported by resources and as a 
tool for clinical staff to provide the best service to the 
patient. The three unfulfilled items of this guideline have 
measured the improvements, keeping updated, and 
rewarding. 
 
The Death rate in isolation room at the period after the 
availability of neutropenic fever guideline is better 
(20,7%) than previous, ie in 2000 (22,5%) and 2002 
(38,8%). Although this number is still higher compared 
with Europe and America. The mortality rate becomes 
very important related to service quality. Based on Health 
Department of Indonesia, one of the indicators in hospital 
service quality assessment is Gross Death Rate (GDR). 
GDR is whole of mortality rate that occurred both before 
and after 48 hours compared to 1000 outpatients. 
 
Although the death rate was higher in older age and 
women, statistically age and gender differences did not 
significantly affect neutropenic fever death rate (p=0,409 
and p=0,404). Whether it is related to physical and 
emotional condition still needs to be proven.9 Age, gender, 
and type of chemotherapy actually are marginally 
significant’s factors. 
 
The proportion of death cases was higher in patients who 
bear a third party (26,8%) than personal (10%), although 
not statistically significant (p=0,065). This is caused by a 
third party did not fully warrant the cost. They used cost-
sharing system, so patients with financial constraints 
would face treatment problems, such as the selection of 
antibiotics and other unaccounted examinations. 
 
In terms of degree of risk factors, the mortality rate was 
higher in high-risk (22,3%) than moderate (0%) or low 
(0%), although not statistically significant. It could be 
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understood because most cases which treated in isolation 
room was acute leukemia (90%). High frequency of 
mortality rate in high-risk may be due to the availability of 
some equipment, such as sterile rooms, human resources, 
and better service system including the availability of 
neutropenic fever guideline. 
 
This study obtain adherence to management algorithm 
(33,3%) had a very significant effect on death rate 
compared to disobedient (p=14,7%) (p=0,043). The 
disobedient of doctors to the principle of treatment that 
caused mortality rate by 14,3% was due to delays in 
empiric antibiotics, non-bactericidal empirical, or narrow-
spectrum antibiotics, and consent from the third party. 
Other possibilities were patients came on holiday so that 
constrained the problem of a person in charge agreement 
and the availability of antibiotic in pharmaceutical 
installation. 
 
Although patients should receive their initial treatment 
within an hour of presentation to an emergency 
department, this goal is problematic for many reasons, 
such as clinical and administration. For example, patients 
must be properly evaluated with laboratory tests and 
radiographs to determine neutropenia and identify a 
possible source of infection.10 Meisenberg B, et al showed 
the longest delayed treatment were a consequence of the 
conscious or functional decision to pause the delivery of 
antibiotics while awaiting transfer to an inpatient unit. This 
delayed treatment is a result of lack of appreciation for the 
pathophysiology of infection and potential sepsis. 
 
To answer the objectives of this study, a multivariate 
analysis should be established. Because there was only 
one variable (adherence to management algorithm) that 
was significant, multivariate analysis was not done. 
 
 
CONCLUSIONS AND RECOMMENDATIONS 
 
The mortality rate of febrile neutropenia fever during 
2008-2012 (20,7%) in isolation room, Dharmais Hospital 
was better than 2000 (22,5%) and 2002 (38,8%). The 
effect of age, sex, and degree of risk factors did not differ 
significantly to mortality (p=0,477, 0,404, 0,324). The 
proportion of mortality rates was higher in case with the 
third person in charge (26,8%) than private (10%) 
although statistically was not significant (p=0,065). From 
the three types of adherence, only adherence to the flow of 
treatment that had a significant effect on mortality rate 
(p=0,033). A significant in this case to stop antibiotic or 
antifungal treatment according to the degree of risk. This 
was caused by the doctors in charge in isolation room are 
consultant of hematology and medical oncology who had 
the competence, awareness, and understanding of the 
guideline. 
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Table 1. Variable Characteristic Based on Age, Gender, A Person In Charge 
 
Variable Frequency Percentage 
Group of age: 
13-38 years old 
>38 years old 
58 
53 
52,3 
47,7 
Gender: 
Men 
Women 
47 
64 
42,3 
57,7 
Person in charge 
Personal 
Third party 
40 
71 
36 
64 
The degree of risk factor 
Low 
Moderate 
High 
5 
3 
103 
4,5 
2,7 
92,8 
 
Table 2. Variable of Physician Compliance to Guideline of Neutropenic Fever Management 
 
Variable of compliance Frequency (n) Percentage (%) 
Management algorithm 
Obedient 
Disobedient 
75 
36 
67,6 
32,4 
Treatment principal 
Obedient 
Disobedient 
90 
21 
81,1 
18,9 
Starting treatment 
Obedient 
Disobedient 
90 
21 
81,1 
18,9 
 
Table 3. Relationship between Adherence to Guideline of Neutropenic Fever Management 
and Death Rate 
 
Variable of compliance 
Number of life 
N (%) 
Number of death 
N (%) 
P value 
Management algorithm 
Obedient 
Disobedient 
71 (84,5) 
17 (63,0) 
13 (15,5) 
10 (37,0) 
0,033* 
Treatment principal 
Obedient 
Disobedient 
70 (77,8) 
18 (85,7) 
20 (22,2) 
3 (14,3) 
0,556** 
Starting treatment 
Obedient 
Disobedient 
70 (77,8) 
18 (85,7) 
20 (22,2) 
3 (14,3) 
0,556* 
*Chi-Square Test 
**Fisher’s Exact Test 
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Table 4. Relationship between Other Factors and Death Rate 
 
Variable 
Number of life 
N (%) 
Number of death 
N (%) 
P value 
Group of age: 
13-38 years old 
>38 years old 
48 (82,8) 
40 (75,5) 
10 (17,2) 
13 (24,5) 
0,477* 
Gender: 
Men 
Women 
35 (74,5) 
53 (82,8) 
12 (25,5) 
11 (17,2) 
0,404* 
Person in charge 
Personal 
Third party 
36 (90,0) 
52 (73,2) 
4 (10,0) 
19 (26,8) 
0,065* 
The degree of risk factor 
Low 
Moderate 
High 
5 (100) 
3 (100) 
80 (77,7) 
0 (0) 
0 (0) 
23 (22,3) 
0,324** 
*Chi Square Test 
**Fisher’s Exact Test 
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